Janmeet Anant, PhD MilliporeSigma

Janmeet Anant, Ph.D., PMP, RAC serves as a Senior Regulatory Consultant at MilliporeSigma, specifically working on sterile injectables. Janmeet has consulted on regulatory requirements for CMC submissions for oligonucleotides, such as siRNA and viral-vector based gene therapies.  Janmeet has guided clients from large multi-national biopharmaceutical and emerging biotech companies through these niche therapeutic modalities, where limited established regulatory guidance exists at present.

Janmeet has been a key member of the Paradigm Change in Manufacturing Operations (PCMO), which is a Quality Risk Management (QRM) team of the Parenteral Drug Association (PDA). In addition, Janmeet has served previously as an Executive Board Member for the Bioprocess Systems Alliance (BPSA), Vice-Chair of a subcommittee of the American Society of Mechanical Engineers - Bioprocessing Equipment (ASME-BPE) standard setting organization, and a member of the Regulatory Governance Team at BioPhorum. With over 20 years of experience in the biopharmaceutical industry, Janmeet has been consulting on complex regulatory strategy projects with biopharmaceutical drug manufacturers, leveraging skills from his Project Management Professional (PMP) and Regulatory Affairs Certification (RAC). Janmeet has a Bachelor of Science degree in Chemistry and a PhD in Pharmacology.